Cargando…
Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancer
BACKGROUND: Malignant bowel obstruction (MBO) is a common cause of morbidity and mortality in women diagnosed with ovarian cancer. Earlier detection of MBO may improve patient outcomes. There are currently no screening tools to assist detection. AIM: We report a screening questionnaire that can be u...
Autores principales: | Morgan, Robert D, Stamatopoulou, Sofia, Mescallado, Nerissa, Saunders, Geoff, Welch, Richard, Mitchell, Claire, Hasan, Jurjees, Clamp, Andrew R, Jayson, Gordon C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435240/ https://www.ncbi.nlm.nih.gov/pubmed/30962962 http://dx.doi.org/10.1136/esmoopen-2018-000463 |
Ejemplares similares
-
Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational Status
por: Logue, Chloe A., et al.
Publicado: (2021) -
Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer
por: Jayson, Gordon C., et al.
Publicado: (2018) -
Palliative home parenteral nutrition in patients with ovarian cancer and malignant bowel obstruction: experiences of women and family caregivers
por: Sowerbutts, Anne Marie, et al.
Publicado: (2019) -
A first-in-human Phase I dose-escalation trial of the novel therapeutic peptide, ALM201, demonstrates a favourable safety profile in unselected patients with ovarian cancer and other advanced solid tumours
por: El Helali, Aya, et al.
Publicado: (2022) -
Profiling Heparan Sulfate Proteoglycans in Ovarian Carcinoma
por: Clamp, Andrew R., et al.
Publicado: (2005)